Search for: "Dr. Reddy" Results 361 - 380 of 395
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 May 2016, 8:58 am by Brian Cordery
It is necessary to avoid a mechanistic approach, and to compare the disclosures of the application as filed and the patent, through the eyes of the skilled person, in order to answer the overall question of whether the skilled person would learn new technical subject matter which was not disclosed in the application” Novelty In relation to the first citation, patent application “WO885”, Carr J applied Dr Reddy’s v Eli Lilly [2010] and considered whether the… [read post]
1 Jan 2019, 5:10 pm by Ben Vernia
On December 21, the Department of Justice announced that during 2018, it had recovered more than $2.8 billion under the False Claims Act. [read post]
4 Aug 2011, 10:20 am by The Legal Blog
Sathasivam Supreme Court of India The Supreme Court in Padal Venkata Rama Reddy @ Ramu Vs. [read post]
4 Oct 2023, 6:30 am by Guest Blogger
For the Balkinization Symposium on The Chevron Doctrine through the Lens of Comparative LawRaeesa Vakil  Indian courts do not formally acknowledge deference to executive interpretations of law. [read post]
4 Jun 2014, 6:36 am
(Pix (c) Larry Catá Backer 2014)Venkatesh Nayak, Programme Coordinator, Access to Information Programme, Commonwealth Human Rights Initiative in New Delhi, has requested the circulation of the following essay, entitled "Promulgating Ordinances – Public Scrutiny and Judicial Review. [read post]
28 Mar 2023, 9:44 am by James Love
Reddy’s, Intas Pharmaceuticals, or BDR Pharmaceuticals), to supply patients purchasers through the Federal Supply Schedule, as well as the Medicare and Medicaid programs. [read post]
27 Sep 2009, 2:30 pm
Teva and Myland and Dr. [read post]
1 Mar 2021, 5:34 am by Ben Millson (Bristows)
Turning to de minimis, Arnold LJ noted that it was common ground that his own statement of the law in Napp v Dr Reddy’s [2016] EWHC 1517 (Pat) was accurate, and analysed whether three “groups” of infringement were de minimis. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
10 Aug 2012, 8:48 am
In relation to the first obviousness attack - the Agrevo attack - Contour cited Jacob LJ's comment in Dr. [read post]